Skip to main content
logo
Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.260
+0.110 (3.49%)
At close: Aug 11, 2026, 4:00 PM EDT
3.251
-0.009 (-0.29%)
After-hours: Aug 11, 2026, 7:52 PM EDT

Prime Medicine Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.064.632.98---
Revenue Growth
-50.62%55.28%----
Gross Profit
2.064.632.98---
Operating Income
-196.52-208.35-202.47-204.79-116.54-84.47
Net Income
-187.89-201.14-195.88-198.13-142.01-184.12
Earnings Per Share
-1.08-1.35-1.65-2.18-4.19-14.19
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
95.07177.68190.44121.67293.92269.62
Total Debt
112.48116.4340.7913.6328.7510.41
Net Cash (Debt)
-17.4161.25149.65108.03265.18259.21
Net Cash Growth
--59.07%38.52%-59.26%2.30%386.07%
Net Cash Per Share
-0.100.411.261.197.8219.98

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-156.05-162.56-122.87-165.41-131.83-34.08
Capital Expenditures
-0.8-4.53-7.29-8.72-16.1-4.15
Free Cash Flow
-156.85-167.1-130.16-174.14-147.92-38.23
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-9525.93%-4498.06%-6787.36%---
Pretax Margin
-9107.71%-4342.44%-6566.61%---
Profit Margin
-9107.71%-4342.44%-6566.61%---
FCF Margin
-7602.91%-3607.41%-4363.36%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
142.39135.23128.39---